IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees-Reference-Cited by-同舟云学术

IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees

Published:2020-11-05 Issue:21 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Fischinger Stephanie^ORCID,Dolatshahi Sepideh^ORCID,Jennewein Madeleine F.,Rerks-Ngarm Supachai,Pitisuttithum Punnee,Nitayaphan Sorachai,Michael Nelson,Vasan Sandhya^ORCID,Ackerman Margaret E.,Streeck Hendrik^ORCID,Alter Galit^ORCID

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/140925/files/pdf

Reference35 articles.

1. WHO. Prevent HIV, test and treat all - WHO support for country impact- Progress report 2016. World Health Organization. https://www.who.int/hiv/pub/progressreports/2016-progress-report/en/ Accessed October 6, 2020

2. Lessons learned from HIV vaccine clinical efficacy trials;Day;Curr HIV Res,2013

3. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

4. Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

5. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Waning immunity and IgG4 responses following bivalent mRNA boosting;Science Advances;2024-02-23

2. Investigation of Immunostimulatory Effects of IFN‐γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV‐1 Therapeutic Vaccine Candidate;Advanced Biology;2023-10-15

3. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response;PLOS Pathogens;2023-05-31

4. Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial;Vaccine;2023-04

5. Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA;Frontiers in Immunology;2023-02-02